New Immunotherapy Drug Shows Striking Early Results in Advanced Prostate CancerBy Andrew RogersFebruary 28, 2026 A new immunotherapy drug has delivered encouraging results for men with advanced prostate cancer. Early data show tumour shrinkage in…
Daily GLP-1 Pill Delivers Greater Weight Loss in Diabetes TrialBy Andrew RogersFebruary 27, 2026 A once-daily pill helped people with type 2 diabetes lose significant weight in a major trial.The drug, orforglipron, activates GLP-1…
New HIV Strategy Could Cut Cases 70%By Grace JohnsonFebruary 26, 2026 A recent study linked to the U.S. National Institutes of Health (NIH) highlights a new approach that could dramatically reduce…
Regulator delays UK puberty blocker trial over safety and age concernsBy Andrew RogersFebruary 23, 2026 UK regulators have halted a clinical trial on puberty blockers for children. They warned about uncertain long-term biological risks and…
Single Nasal Vaccine Could Offer Broad Protection Against Flu, Colds and Lung IllnessesBy Grace JohnsonFebruary 21, 2026 US researchers say a single nasal spray vaccine could protect against coughs, colds and flu. The vaccine could also prevent…
Weight-Loss Pills Accelerate Pharma’s Obesity Drug BoomBy Andrew RogersFebruary 15, 2026 Daily GLP-1 tablets are reshaping the race for the obesity market.Analysts say easier treatment could push the sector toward a…
Measles Threaten Europe Again as Vaccination Hesitancy PersistsBy Grace JohnsonFebruary 15, 2026 Health agencies warn that measles continue to pose a serious threat in Europe, despite a decline in cases in 2025…
Brain Training May Delay DementiaBy Grace JohnsonFebruary 14, 2026 A new NIH-funded study suggests that cognitive training activities could delay the onset of dementia. Researchers found that regularly engaging…
Exercise Could Be Frontline Treatment for Mild Depression, Study SuggestsBy Andrew RogersFebruary 11, 2026 Aerobic exercise such as running, swimming or dancing can act as a frontline treatment for mild depression and anxiety, researchers…
Moderna’s mRNA Flu Vaccine Faces FDA Roadblock in Approval ProcessBy Grace JohnsonFebruary 11, 2026 FDA Refuses to Review Seasonal Flu Shot The US Food and Drug Administration refused to accept Moderna’s application to review…
